Reply to: Methodologic reporting requirements for clinical trials?

G. A. Poland

doi:10.1016/j.vaccine.2011.09.116

Reply to: Methodologic reporting requirements for clinical trials?

G. A. Poland

General Internal Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	9579
Number of pages	1
Journal	Vaccine
Volume	29
Issue number	52
DOIs	https://doi.org/10.1016/j.vaccine.2011.09.116
State	Published - Dec 6 2011

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2011.09.116

Cite this

@article{cd154f3d99b64a938a8c9d52081230d4,

title = "Reply to: Methodologic reporting requirements for clinical trials?",

author = "Poland, {G. A.}",

year = "2011",

month = dec,

day = "6",

doi = "10.1016/j.vaccine.2011.09.116",

language = "English (US)",

volume = "29",

pages = "9579",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "52",

}

TY - JOUR

T1 - Reply to

T2 - Methodologic reporting requirements for clinical trials?

AU - Poland, G. A.

PY - 2011/12/6

Y1 - 2011/12/6

UR - http://www.scopus.com/inward/record.url?scp=82555192814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82555192814&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.09.116

DO - 10.1016/j.vaccine.2011.09.116

M3 - Letter

AN - SCOPUS:82555192814

SN - 0264-410X

VL - 29

SP - 9579

JO - Vaccine

JF - Vaccine

IS - 52

ER -

Reply to: Methodologic reporting requirements for clinical trials?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this